VPTDF (VentriPoint Diagnostics) Long-Term Capital Lease Obligation : $0.11 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is VentriPoint Diagnostics Long-Term Capital Lease Obligation?

VentriPoint Diagnostics's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.11 Mil.

VentriPoint Diagnostics's quarterly Long-Term Capital Lease Obligation declined from Jun. 2024 ($0.14 Mil) to Sep. 2024 ($0.13 Mil) and declined from Sep. 2024 ($0.13 Mil) to Dec. 2024 ($0.11 Mil).

VentriPoint Diagnostics's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.20 Mil) to Dec. 2023 ($0.16 Mil) and declined from Dec. 2023 ($0.16 Mil) to Dec. 2024 ($0.11 Mil).

VentriPoint Diagnostics Long-Term Capital Lease Obligation Historical Data

The historical data trend for VentriPoint Diagnostics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Long-Term Capital Lease Obligation Chart

VentriPoint Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.03

0.20

0.16

0.11

VentriPoint Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.16	0.15	0.14	0.13	0.11

VentriPoint Diagnostics (OTCPK:VPTDF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

VentriPoint Diagnostics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (OTCPK:VPTDF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

VPT:Canada

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics Headlines

From GuruFocus

Q4 2022 VentriPoint Diagnostics Ltd Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Q1 2023 VentriPoint Diagnostics Ltd Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Q2 2023 VentriPoint Diagnostics Ltd Earnings Call Transcript

By GuruFocus Research • 02-15-2024